Opaleye Management Inc. Quant / Systematic

CIK: 0001595855 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 14, 2024

Total Value ($000): $437,657 (98.2% shares, 1.8% debt)

Holdings (51)

HROW HARROW HEALTH INC 19.0%
Value ($000) $83,351 Shares 3,990,000 Est. Cost $6.33 Unrealized +136.1%
TGTX TG THERAPEUTICS INC 9.3%
Value ($000) $40,561 Shares 2,280,000 Est. Cost $13.67 Unrealized +16.8%
OCUL OCULAR THERAPEUTIX INC 8.3%
Value ($000) $36,303 Shares 5,307,500 Est. Cost $5.10 Unrealized +21.1%
RYTM RHYTHM PHARMACEUTICALS INC 4.8%
Value ($000) $21,146 Shares 515,000 Est. Cost $12.73 Unrealized +213.5%
KROS KEROS THERAPEUTICS INC 3.8%
Value ($000) $16,795 Shares 367,500 Est. Cost $47.67 Unrealized +12.7%
ARVN ARVINAS INC 3.4%
Value ($000) $14,774 Shares 555,000 Est. Cost $29.24 Unrealized +9.0%
IMNM IMMUNOME INC 3.0%
Value ($000) $13,340 Shares 1,102,500 Est. Cost $15.64 Unrealized 0.0%
CYTK CYTOKINETICS INC 2.5%
Value ($000) $10,755 Shares 198,500 Est. Cost $60.36 Unrealized 0.0%
CDXS CODEXIS INC 2.4%
Value ($000) $10,711 Shares 3,455,000 Est. Cost $2.59 Unrealized +24.2%
EWTX EDGEWISE THERAPEUTICS INC 2.4%
Value ($000) $10,446 Shares 580,000 Est. Cost $10.13 Unrealized +72.2%
CPRX CATALYST PHARMACEUTICALS INC 2.3%
Value ($000) $9,914 Shares 640,000 Est. Cost $13.39 Unrealized +16.3%
CARGO THERAPEUTICS INC 2.1%
Value ($000) $9,125 Shares 555,700 Est. Cost $16.42 Unrealized
JSPR JASPER THERAPEUTICS INC 2.0%
Value ($000) $8,898 Shares 392,000 Est. Cost $17.76 Unrealized +35.0%
NRIX NURIX THERAPEUTICS INC 2.0%
Value ($000) $8,743 Shares 418,928 Est. Cost $12.50 Unrealized +24.6%
TRVI TREVI THERAPEUTICS INC 1.8%
Value ($000) $7,882 Shares 2,645,000 Est. Cost $2.06 Unrealized +35.0%
ETON ETON PHARMACEUTICALS INC 1.8%
Value ($000) $7,880 Shares 2,395,000 Est. Cost $5.82 Unrealized -39.8%
APPLIED THERAPEUTICS INC' 1.8%
Value ($000) $7,846 Shares 1,680,000 Est. Cost $4.24 Unrealized
FDMT 4D MOLECULAR THERAPEUTICS INC 1.7%
Value ($000) $7,257 Shares 345,750 Est. Cost $20.37 Unrealized +23.2%
IOVA IOVANCE BIOTHERAPEUTICS INC 1.6%
Value ($000) $7,194 Shares 897,000 Est. Cost $6.29 Unrealized +70.4%
ACELYRIN INC 1.6%
Value ($000) $6,968 Shares 1,580,000 Est. Cost $20.90 Unrealized
URGN UROGEN PHARMA LTD 1.6%
Value ($000) $6,913 Shares 412,000 Est. Cost $10.29 Unrealized +38.3%
PCVX VAXCYTE INC 1.5%
Value ($000) $6,418 Shares 85,000 Est. Cost $38.73 Unrealized +75.7%
BIODESIX INC 1.4%
Value ($000) $6,151 Shares 4,020,000 Est. Cost $2.17 Unrealized
NAMS NEWAMSTERDAM PHARMA COMPANY 1.4%
Value ($000) $6,051 Shares 315,000 Est. Cost $10.93 Unrealized +83.6%
XOMA XOMA CORP DEL 1.4%
Value ($000) $5,923 Shares 250,000 Est. Cost $11.26 Unrealized +122.0%
TARA PROTARA THERAPEUTICS INC 1.2%
Value ($000) $5,300 Shares 2,304,262 Est. Cost $29.10 Unrealized -90.0%
NTLA INTELLIA THERAPEUTICS INC 1.1%
Value ($000) $4,879 Shares 218,000 Est. Cost $28.15 Unrealized -15.4%
NUVL NUVALENT INC 1.0%
Value ($000) $4,498 Shares 59,300 Est. Cost $71.13 Unrealized 0.0%
SYRS SYROS PHARMACEUTICALS INC 1.0%
Value ($000) $4,466 Shares 865,443 Est. Cost $5.32 Unrealized -1.2%
GOSSAMER BIO INC 0.9%
Value ($000) $3,958 Shares 8,000,000 Est. Cost $0.39 Unrealized
LQDA LIQUIDIA CORPORATION 0.9%
Value ($000) $3,900 Shares 325,000 Est. Cost $5.52 Unrealized +140.4%
KARYOPHARM THERAPEUTICS INC 0.9%
Value ($000) $3,747 Shares 6,000,000 Est. Cost $0.62 Unrealized
PTGX PROTAGONIST THERAPEUTICS INC 0.8%
Value ($000) $3,638 Shares 105,000 Est. Cost $17.50 Unrealized +67.4%
GOSS GOSSAMER BIO INC 0.8%
Value ($000) $3,523 Shares 3,910,000 Est. Cost $1.04 Unrealized -28.2%
LXRX LEXICON PHARMACEUTICALS INC 0.7%
Value ($000) $3,150 Shares 1,875,000 Est. Cost $1.79 Unrealized 0.0%
SVRA SAVARA INC 0.7%
Value ($000) $2,881 Shares 714,960 Est. Cost $4.83 Unrealized -7.9%
ALLAKOS INC 0.6%
Value ($000) $2,780 Shares 2,780,000 Est. Cost $1.23 Unrealized
VTYX VENTYX BIOSCIENCES INC 0.6%
Value ($000) $2,749 Shares 1,190,000 Est. Cost $8.94 Unrealized -53.5%
VSTM VERASTEM INC 0.6%
Value ($000) $2,727 Shares 915,000 Est. Cost $8.26 Unrealized -0.2%
REGULUS THERAPEUTICS INC 0.6%
Value ($000) $2,633 Shares 1,475,000 Est. Cost $1.91 Unrealized
LYELL IMMUNOPHARMA INC 0.6%
Value ($000) $2,422 Shares 1,670,000 Est. Cost $2.23 Unrealized
RLMD RELMADA THERAPEUTICS INC 0.4%
Value ($000) $1,800 Shares 600,000 Est. Cost $2.96 Unrealized +22.2%
FULC FULCRUM THERAPEUTICS INC 0.4%
Value ($000) $1,767 Shares 285,000 Est. Cost $6.14 Unrealized +23.3%
KARYOPHARM THERAPEUTICS INC 0.3%
Value ($000) $1,236 Shares 1,425,000 Est. Cost $0.87 Unrealized
IBIO IBIO INC 0.2%
Value ($000) $791 Shares 375,000 Est. Cost $1.26 Unrealized +71.0%
PMVP PMV PHARMACEUTICALS INC 0.2%
Value ($000) $770 Shares 475,000 Est. Cost $1.87 Unrealized -3.4%
AEROVATE THERAPEUTICS INC 0.2%
Value ($000) $730 Shares 440,000 Est. Cost $1.66 Unrealized
DSGN DESIGN THERAPEUTICS INC 0.2%
Value ($000) $687 Shares 205,000 Est. Cost $3.22 Unrealized +21.0%
ABCL ABCELLERA BIOLOGICS INC 0.1%
Value ($000) $592 Shares 200,000 Est. Cost $3.78 Unrealized 0.0%
ALIGOS THERAPEUTICS INC 0.1%
Value ($000) $441 Shares 1,260,000 Est. Cost $0.73 Unrealized
RENEO PHARMACEUTICALS INC 0.1%
Value ($000) $249 Shares 165,000 Est. Cost $1.51 Unrealized